Adult ADHD treatment surges as stimulant prescriptions more than double since the COVID-19 pandemic began, as a new study reveals a dramatic healthcare trend.

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

Finding the right ADHD prescription can feel overwhelming at first. With dozens of stimulant and nonstimulant ADHD medications available, many people search for clarity on how these medications work, ...

New ADHD stimulant prescriptions among adults have more than doubled since the COVID-19 pandemic, raising questions about diagnosis patterns and treatment practices.

For years, stimulant medications for ADHD have been described as chemical accelerators, framed as drugs that rev up a sluggish brain. New imaging work turns that story on its head. Brain scans now ...

“You forgot to include my address on the script, so the pharmacy won’t fill my prescription.” The words fell out of my mouth while I pressed my palm against the edge of my kitchen island. Source: ...

Stimulant medications like methylphenidate (Ritalin) and lisdexamfetamine (Vyvanse) are dispensed at a rate of 6.1 prescriptions per 100 Americans annually, rising to 24.6 per 100 among boys aged ...

Understood reports ADHD meds may raise heart risks; lifestyle factors like sleep issues and weight gain also affect heart ...

It is typically treated with behavioral therapy initially, which may be combined with stimulant or non-stimulant medications to help control behaviors that interfere with daily life and relationships.